XWXiaoqing Wang

Xiaoqing Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoqing Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Guang Zhao

    Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, China

    1 shared publication
  • Jianming Jiang

    Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, China

    1 shared publication
  • Xiaowen Yu

    Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, China

    1 shared publication
  • Xiutian Zhang

    Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, China

    1 shared publication
  • Yangtai Guan

    Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiao Tong University School of Medicine (Punan Hospital in Pudong new district), Shanghai, China

    1 shared publication

Latest Publications

  • Primary central nervous system germinal center B-like diffuse large B-cell lymphoma: a case report

    by X Wang

    We report a case of a 54-year-old HIV-negative female who presented with a 2-month history of ongoing post meridiem low-level fever and new onset progressive paralysis. On MRI (magnetic resonance imaging), an infiltrative enhancing lesion was noted, which initially resembled that of MS, but she reacted not sensitively with immunosuppressive therapy, we performed a brain biopsy to her, it turned out to be primary CNS (central nervous system) diffuse large B-cell lymphoma (DLBCL). And the morphology, the flow cytometric findings were consistent with germinal center B-like diffuse large B-cell lymphoma. There were only a few case reports concerning primary CNS DLBCL of GCB. The misdiagnose of this patient should alarm the bell, and we should consider biopsy when the lesion is near the cortex in the brain. Why she reacted not sensitively with immunosuppressive therapy later is analyzed.


  • Open Access

    Clinical application of clustered-AChR for the detection of SNMG

    by Guang Zhao, Xiaoqing Wang, Xiaowen Yu, Xiutian Zhang, Yangtai Guan, Jianming Jiang

    Myasthenia gravis (MG) is an autoantibody-mediated disease of the neuromuscular junction (NMJ). However, accumulating evidence has indicated that MG patients whose serum anti-acetylcholine receptor (AChR) antibodies are not detectable (serumnegative MG; SNMG) in routine assays share similar clinical features with anti-AChR antibody-positive MG patients. We hypothesized that SNMG patients would have low-affinity antibodies to AChRs that would not be detectable using traditional methods but that might be detected by binding to AChR on the cell membrane, particularly if they were clustered at the high density observed at the NMJ. We expressed AChR subunits with the clustering protein rapsyn (an AChR-associated protein at the synapse) in human embryonic kidney (HEK) cells and we tested the binding of the antibodies using immunofluorescence. With this approach, AChR antibodies to rapsyn-clustered AChR could be detected in the sera from 45.83% (11/24) of SNMG patients, as confirmed with fluorescence-activated cell sorting (FACS). This was the first application in China of cell-based AChR antibody detection. More importantly, this sensitive (and specific) approach could significantly increase the diagnosis rate of SNMG.